Skip to content

BillOkay

Audit hospital bills against official CGHS, NPPA & IRDAI ceiling rates.

Verified ownerFreeLaunching 3 May 2027
Votes revealed at 17:00 UTCVisit billokay.com

Share this page

What it does

About BillOkay

BillOkay is an independent healthcare billing transparency tool designed to help patients and families audit hospital bills in India against official regulatory benchmarks including CGHS, NPPA drug caps, and IRDAI health insurance guidelines.

Short entry · kept out of search results until it grows

Related tools

More in this section

trademarksignal.com

An early-warning line on trademarks near yours

Pricing unlisted

hrcompliancewatch.com

Employment-law changes, translated before they bite

Pricing unlisted

mailpiler.org

Open source email archiving platform for compliance and cost reduction

email-archivingcomplianceFreeUnclaimed
Same launch day

Also on 3 May 2027

app.goldenboxmenu.com

Catering and event menu builder managed 100% in Google Sheets.

Paid · from $49
Votes revealed at 17:00 UTC

restore.click

One-click AI photo restoration, scratch repair, and realistic colorization.

Freemium · from $9
Votes revealed at 17:00 UTC

buildersite.co

High-converting static portfolio & SEO websites for custom home builders.

Paid · from $299
Votes revealed at 17:00 UTC
Badges

Show that BillOkay is in the index

Optional

Copy a snippet onto your site if you want to. Badges are earned status. Your listing stays indexed and ranked whether or not one is embedded. The snippet is a link with an image and no script. The smaller badge, in light or dark and small or large, is on the badge page.

BillOkay: Verified listing on ToolfoundUnlocks once domain ownership is verified.
Verified listing
<a href="https://toolfound.com/tool/billokay" title="Ownership of this listing is verified on Toolfound">
  <img src="https://toolfound.com/api/badge/billokay?variant=verified"
       alt="BillOkay: Verified listing on Toolfound" width="200" height="56" loading="lazy"></a>

Comments

Sign in with email to comment

No comments yet. Be the one who starts it.